SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · Real-Time Price · USD
0.8121
+0.0421 (5.47%)
Oct 13, 2025, 4:00 PM EDT - Market closed
SCYNEXIS Market Cap
SCYNEXIS has a market cap or net worth of $34.05 million as of October 13, 2025. Its market cap has decreased by -40.48% in one year.
Market Cap
34.05M
Enterprise Value
-8.35M
1-Year Change
-40.48%
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since May 2, 2014, SCYNEXIS's market cap has decreased from $76.10M to $34.05M, a decrease of -55.26%. That is a compound annual growth rate of -6.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 34.00M | -25.93% |
| Dec 31, 2024 | 45.90M | -44.70% |
| Dec 29, 2023 | 83.00M | 63.06% |
| Dec 30, 2022 | 50.90M | -65.16% |
| Dec 31, 2021 | 146.10M | 74.55% |
| Dec 31, 2020 | 83.70M | 57.63% |
| Dec 31, 2019 | 53.10M | 129.87% |
| Dec 31, 2018 | 23.10M | -65.16% |
| Dec 29, 2017 | 66.30M | -13.33% |
| Dec 30, 2016 | 76.50M | -11.46% |
| Dec 31, 2015 | 86.40M | 1.65% |
| Dec 31, 2014 | 85.00M | 11.70% |
| May 2, 2014 | 76.10M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |